Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Nautilus Biotechnology, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Nautilus Biotechnology, Inc.Listing on record | Buy | $11.6K | SEC | |
Nautilus Biotechnology, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Nautilus Biotechnology, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Nautilus Biotechnology, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Nautilus Biotechnology, Inc.Listing on record | Buy | $40.3K | SEC | |
Nautilus Biotechnology, Inc.Listing on record | Buy | $15.1K | SEC | |
Nautilus Biotechnology, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Nautilus Biotechnology, Inc.Listing on record | Buy | $68.7K | SEC | |
Nautilus Biotechnology, Inc.Listing on record | Buy | $134.9K | SEC |